CA
NZ
UK
AU
IND
US
…
Ekso Bionics Holdings, Inc. designs, develops, distributes, and commercializes exoskeleton products in the Americas, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company provides EksoNR, a wearable robotic exoskeleton; Ekso Indego Therapy, a powered exoskeleton; Ekso Indego Personal, a powered lower limb orthosis; and Ekso EVO, a wearable upper body exoskeleton. It also develops Ekso Nomad, a power Knee Ankle Foot Orthosis or KAFO; and MediTouch BalanceTutor rehabilitation system, a multidirectional perturbation treadmill outfitted. Ekso Bionics Holdings, Inc. was founded in 2005 and is headquartered in San Rafael, California.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | -11.70M | -11.33M | -15.20M | -15.08M | -9.76M |
| Net income | -11.70M | -11.33M | -15.20M | -14.60M | -8.43M |
| Selling general administrative | 9.99M | 8.79M | 10.69M | 10.99M | 10.52M |
| Selling and marketing expenses | 7.15M | 7.31M | 8.47M | 7.16M | 7.30M |
| Gross profit | 6.84M | 9.51M | 9.70M | 6.21M | 6.75M |
| Reconciled depreciation | 1.57M | 1.61M | 1.28M | 0.89M | 0.56M |
| Ebit | -11.39M | -11.06M | -15.11M | -15.56M | -13.83M |
| Ebitda | -9.81M | -9.45M | -13.41M | -15.59M | -14.71M |
| Depreciation and amortization | 1.57M | 1.61M | 1.70M | -0.03M | -0.88M |
| Operating income | -13.33M | -10.46M | -15.11M | -15.56M | -13.83M |
| Other operating expenses | 26.12M | 28.39M | 33.39M | 28.47M | 25.07M |
| Interest expense | 0.31M | 0.27M | 0.30M | 0.16M | 0.11M |
| Net interest income | -0.31M | -0.27M | -0.30M | -0.16M | -0.11M |
| Income tax expense | - | - | - | -0.48M | -1.33M |
| Total revenue | 12.80M | 17.93M | 18.28M | 12.91M | 11.25M |
| Total operating expenses | 20.17M | 19.97M | 24.81M | 21.77M | 20.58M |
| Cost of revenue | 5.95M | 8.41M | 8.58M | 6.70M | 4.50M |
| Total other income expense net | 1.63M | -0.87M | -0.09M | 0.48M | 4.06M |
| Net income from continuing ops | -11.70M | -11.33M | -15.16M | -15.08M | -9.76M |
| Net income applicable to common shares | - | - | - | - | -9.76M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 20.11M | 26.65M | 28.92M | 40.90M | 49.17M |
| Intangible assets | 3.50M | 4.58M | 4.89M | 5.22M | - |
| Other current assets | 0.75M | 0.54M | 0.88M | 0.70M | 0.48M |
| Total liab | 11.08M | 13.95M | 16.31M | 15.46M | 11.95M |
| Total stockholder equity | 9.03M | 12.71M | 12.61M | 25.44M | 37.22M |
| Other current liab | 3.79M | 2.35M | 2.66M | 2.28M | 2.30M |
| Common stock | 0.04M | 0.02M | 0.01M | 0.01M | 0.01M |
| Capital stock | 0.04M | 0.02M | 0.01M | 0.01M | 0.01M |
| Retained earnings | -262.40M | -250.47M | -239.15M | -223.95M | -208.87M |
| Other liab | - | - | - | 1.41M | 3.10M |
| Good will | 0.43M | 0.43M | 0.43M | 0.43M | - |
| Other assets | - | - | - | - | 0.16M |
| Cash | 1.17M | 6.49M | 8.64M | 20.52M | 40.41M |
| Total current liabilities | 8.64M | 7.54M | 8.12M | 9.20M | 6.86M |
| Current deferred revenue | 1.73M | 1.96M | 1.99M | 1.12M | 1.22M |
| Net debt | 1.47M | -0.51M | -1.47M | -13.02M | -38.18M |
| Short term debt | 1.69M | 1.68M | 1.61M | 2.65M | 0.23M |
| Short long term debt | 3.26M | 1.25M | 1.25M | 2.31M | - |
| Short long term debt total | 2.64M | 5.98M | 7.17M | 7.50M | 2.22M |
| Other stockholder equity | 272.08M | 262.20M | 251.58M | 248.81M | 246.09M |
| Property plant equipment | - | - | - | 3.99M | 1.21M |
| Total current assets | 14.05M | 18.84M | 20.21M | 31.04M | 47.80M |
| Net tangible assets | - | - | - | 19.79M | 37.22M |
| Net receivables | 7.31M | 7.24M | 5.64M | 4.62M | 4.66M |
| Long term debt | 0.80M | 3.85M | 4.83M | 3.77M | 1.99M |
| Inventory | 4.82M | 4.57M | 5.05M | 5.19M | 2.24M |
| Accounts payable | 1.43M | 1.55M | 1.85M | 3.15M | 3.11M |
| Accumulated other comprehensive income | -0.69M | 0.96M | 0.16M | 0.56M | -0.02M |
| Non currrent assets other | 0.31M | 0.43M | 0.39M | 0.23M | 0.16M |
| Non current assets total | 6.06M | 7.81M | 8.71M | 9.87M | 1.37M |
| Capital lease obligations | 0.59M | 0.88M | 1.09M | 1.43M | 0.23M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | - | -0.04M | -5.15M | -5.17M | -0.06M |
| Change to liabilities | - | - | - | -0.61M | 1.05M |
| Total cashflows from investing activities | -0.19M | -0.04M | - | - | -0.06M |
| Net borrowings | -1.32M | -1.25M | - | - | - |
| Total cash from financing activities | 6.63M | 7.77M | 0.35M | 0.18M | 38.71M |
| Change to operating activities | - | - | - | - | 0.86M |
| Net income | -11.70M | -11.33M | -15.20M | -15.08M | -9.76M |
| Change in cash | -5.32M | -2.15M | -11.89M | -19.88M | 27.54M |
| Begin period cash flow | 6.49M | 8.64M | 20.52M | 40.41M | 12.86M |
| End period cash flow | 1.17M | 6.49M | 8.64M | 20.52M | 40.41M |
| Total cash from operating activities | -11.80M | -9.85M | -12.05M | -14.69M | -11.16M |
| Issuance of capital stock | 4.10M | 9.02M | 0.66M | 0.00M | 37.30M |
| Depreciation | 1.57M | 1.61M | 1.70M | 0.89M | 0.56M |
| Other cashflows from investing activities | -0.19M | -0.04M | - | - | - |
| Dividends paid | 0.23M | - | - | - | - |
| Change to inventory | -0.28M | 0.26M | 0.23M | -1.40M | -0.75M |
| Change to account receivables | 0.45M | -1.97M | -1.21M | -0.07M | -1.62M |
| Other cashflows from financing activities | 4.08M | 7.77M | -0.31M | -0.18M | 1.42M |
| Change to netincome | - | - | - | 2.08M | -1.49M |
| Capital expenditures | 0.19M | 0.04M | 0.16M | 0.19M | 0.06M |
| Change in working capital | -2.04M | -2.52M | -0.58M | -2.58M | -0.47M |
| Stock based compensation | 1.47M | 1.63M | 2.24M | 2.73M | 2.50M |
| Other non cash items | -1.11M | 0.77M | 7.33M | -0.65M | 0.13M |
| Free cash flow | -11.99M | -9.88M | -12.21M | -14.88M | -11.21M |
Sector: Healthcare Industry: Medical Instruments & Supplies
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| ISRG Intuitive Surgical Inc |
-8.88 1.97% |
440.65 | 43.30 | 31.35 | 12.25 | 7.35 | 11.63 | 30.22 |
| ESLOF EssilorLuxottica Société anonyme |
-2.56 1.26% |
200.18 | 44.84 | 27.62 | 4.07 | 2.49 | 3.71 | 16.04 |
| ESLOY Essilor International SA |
-1.98 1.94% |
99.87 | 41.68 | 27.25 | 3.94 | 2.45 | 3.71 | 16.04 |
| BDX Becton Dickinson and Company |
0.83 0.39% |
215.35 | 31.62 | 13.76 | 2.25 | 2.04 | 2.93 | 13.40 |
Ekso Bionics Holdings, Inc. designs, develops, distributes, and commercializes exoskeleton products in the Americas, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company provides EksoNR, a wearable robotic exoskeleton; Ekso Indego Therapy, a powered exoskeleton; Ekso Indego Personal, a powered lower limb orthosis; and Ekso EVO, a wearable upper body exoskeleton. It also develops Ekso Nomad, a power Knee Ankle Foot Orthosis or KAFO; and MediTouch BalanceTutor rehabilitation system, a multidirectional perturbation treadmill outfitted. Ekso Bionics Holdings, Inc. was founded in 2005 and is headquartered in San Rafael, California.
| Name | Title | Year Born |
|---|---|---|
| Mr. Scott G. Davis | CEO & Director | 1970 |
| Mr. Jerome Wong | Corp. Controller, Corp. Sec. & CFO | 1974 |
| Ms. Rachael Anderson | Global Director of Marketing & Strategic Growth | NA |
| Mr. Anthony Pratt | VP of Sales | NA |
| Ms. Ann Cookson | HR Director | NA |
| Ms. Foon Lim Chwee | Pres of APAC | NA |
| Mr. Jason C. Jones | Sr. VP of Product Devel. | NA |
| Mr. Stephan Aderhold | Sr. VP & GM of EMEA | NA |
| Mr. Jerome Wong | Corporate Controller, Corporate Secretary & CFO | 1974 |
| Mr. Jason C. Jones | Chief Operating Officer | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.
Download a free report with stock ideas and industry insights for general information.
Download Free Report Now →
Basic Materials
-1.40%
Communication Services
-0.45%
Consumer Cyclical
-0.55%
Consumer Defensive
-0.01%
Energy
-0.01%
Financial Services
-0.40%
Financials
-0.15%
Healthcare
-1.15%
Industrials
-0.46%
Real Estate
-0.29%
Technology
-1.22%
Utilities
-0.10%
Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.
Portfolio
Watchlist
+0.55%
Please wait processing your request...